• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disparities in clinical trial participation among older adults with multiple myeloma in the United States.

作者信息

White Priscila, Cooley Abigail, Bal Susan, Godby Kelly, Ravi Gayathri, Clark Deanna, Ubersax Clare, Williams Grant R, Costa Luciano J, Giri Smith

机构信息

Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America; Institute for Cancer Outcomes and Survivorship, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America.

Division of Hematology and Oncology, Department of Medicine, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States of America.

出版信息

J Geriatr Oncol. 2022 Nov;13(8):1241-1243. doi: 10.1016/j.jgo.2022.07.001. Epub 2022 Jul 28.

DOI:10.1016/j.jgo.2022.07.001
PMID:35907703
Abstract
摘要

相似文献

1
Disparities in clinical trial participation among older adults with multiple myeloma in the United States.美国老年多发性骨髓瘤患者在临床试验参与方面的差异。
J Geriatr Oncol. 2022 Nov;13(8):1241-1243. doi: 10.1016/j.jgo.2022.07.001. Epub 2022 Jul 28.
2
Multiple myeloma and diagnostic imaging.多发性骨髓瘤与诊断性影像学
Radiol Technol. 2014 Mar-Apr;85(4):391-410; quiz 411-3.
3
Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data.多发性骨髓瘤老年患者生存率的提高：SEER 数据更新期分析结果。
Oncologist. 2011;16(11):1600-3. doi: 10.1634/theoncologist.2011-0229. Epub 2011 Oct 3.
4
Novel Treatments for Multiple Myeloma: What Role Do They Have in Older Adults?多发性骨髓瘤的新型治疗方法：它们在老年人中发挥着什么作用？
Drugs Aging. 2018 Apr;35(4):289-302. doi: 10.1007/s40266-018-0539-1.
5
Emerging therapies for multiple myeloma: Application in older adults.多发性骨髓瘤的新兴疗法：在老年人中的应用。
J Geriatr Oncol. 2017 Nov;8(6):413-416. doi: 10.1016/j.jgo.2017.07.006. Epub 2017 Jul 26.
6
Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide.老年多发性骨髓瘤患者管理的最新观点：关注来那度胺。
Clin Interv Aging. 2020 May 4;15:619-633. doi: 10.2147/CIA.S196087. eCollection 2020.
7
Clinical trials referral resource. Current clinical trials in multiple myeloma.临床试验转诊资源。多发性骨髓瘤的当前临床试验。
Oncology (Williston Park). 2004 Feb;18(2):196-8, 203.
8
Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?老年多发性骨髓瘤患者的自体移植：我们提出的问题正确吗？
Bone Marrow Transplant. 2006 Nov;38(9):585-92. doi: 10.1038/sj.bmt.1705486. Epub 2006 Sep 4.
9
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.在 Medicare 人群中，多发性骨髓瘤的表现、治疗、护理费用和结果的趋势：全面了解种族差异。
Cancer. 2018 Apr 15;124(8):1710-1721. doi: 10.1002/cncr.31237. Epub 2018 Jan 23.
10
The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myeloma.80岁及以上老年多发性骨髓瘤患者的特征、治疗模式及预后
J Geriatr Oncol. 2020 Nov;11(8):1274-1278. doi: 10.1016/j.jgo.2020.03.005. Epub 2020 Mar 10.

引用本文的文献

1
Clinical outcomes after idecabtagene vicleucel in older patients with multiple myeloma: a multicenter real-world experience.多发性骨髓瘤老年患者接受 idecabtagene vicleucel 治疗后的临床结局：一项多中心真实世界经验。
Blood Adv. 2024 Sep 10;8(17):4679-4688. doi: 10.1182/bloodadvances.2024013540.
2
More intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected].强化疗法对多发性骨髓瘤衰弱患者更有效[已更正]。
Blood Adv. 2023 Oct 24;7(20):6275-6284. doi: 10.1182/bloodadvances.2023011019.